Navigation Links
Amgen’s Second Quarter 2011 Revenue Increased 4 Percent to $4.0 Billion
Date:7/29/2011

lated expenses

(g)0.02Tax benefit for prior period charges

(h)(0.01)"Adjusted" EPS (diluted) guidance$
5.00

-

$
5.20*The known adjustments are presented net of their related aggregate tax impact of approximately $0.26 per share. (a)To exclude the ongoing, non-cash amortization of acquired product technology rights, primarily ENBREL, related to the Immunex acquisition.(b)To exclude the incremental non-cash interest expense resulting from a change in accounting in January 2009related to our convertible debt. (c)To exclude stock option expense.(d)To exclude charges associated with the BI Fremont transaction involving our manufacturing operation in Fremont, California.(e)To exclude the ongoing, non-cash amortization of the R&D technology intangible assets acquired with the Abgenixand Avidia acquisitions.(f)To exclude certain charges pursuant to our continuing efforts to improve cost efficiencies in our manufacturing operations.(g)To exclude merger-related expenses associated with our recent acquisitions.(h)To exclude the income tax benefit related principally to certain prior period charges excluded from "Adjusted" earnings.Amgen Inc.Reconciliation of GAAP R&D Expenses as a Percentage of Product Sales Guidance to "Adjusted" R&D Expenses as a Percentage of Product Sales Guidance for the Year Ending December 31, 2011(Unaudited)On July 29, 2011, the Company stated that the full year adjusted R&D expenses are expected to be at the upper end of the range of 18% to 20% of product sales. 2011GAAP R&D expenses as a percentage of product sales guidance18.4%

-

20.4%Known adjustments, related to stock option and merger-related expenses, to arrive at “Adjusted” R&D expenses as a percentage of product sales(0.4%)"Adjusted" R&D expenses as a percentage of product sales guidance18.0%

-

20.0%Amgen Inc.R
'/>"/>

SOURCE Amgen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine technology :

1. Amgen’s Third Quarter 2010 Revenue Unchanged at $3.8 Billion Versus Prior Year
2. Amgen’s Fourth Quarter 2010 Adjusted Earnings Per Share Increased 11 Percent to $1.17; Full Year 2010 Adjusted Earnings Per Share Increased 6 Percent to $5.21
3. Amgen’s First Quarter 2011 Revenue Increased 3 Percent to $3.7 Billion
4. Spherix Reports Second Quarter Earnings
5. Tapestry Reports Second Quarter 2007 Results
6. Callisto Reports on Second-Quarter 2007 Milestones
7. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
8. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
9. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
10. Vical Reports Second Quarter 2007 Financial Results, Allowance of Pandemic Influenza IND and Other Advances in Product Development Programs
11. Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015  Immune Therapeutics, Inc. today announced the ... the compounding, packaging and distributing of its naltrexone tablets.  The ... United States . KRS Global is ... tablets in various strengths for individual patients in response to ...
(Date:1/23/2015)...  iMD Companies, Inc. (ICBU) has repositioned itself as a holding ... a foothold in the hydroponic, hemp and medical marijuana sectors. ... in the sector, and recently partnering with the Chippewa Tribe ... medical marijuana, iMD is committing to bring its vision to ...
(Date:1/23/2015)... Jan. 23, 2015  Mallinckrodt plc (NYSE: MNK ... approved a share repurchase program. The open-ended authorization permits ... Mallinckrodt plc ordinary shares. "Funding additional ... priorities as we continue to pursue a range of ...
Breaking Medicine Technology:Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2Mallinckrodt plc Announces Share Repurchase Program 2Mallinckrodt plc Announces Share Repurchase Program 3Mallinckrodt plc Announces Share Repurchase Program 4
... Va., Oct. 30 CEL-SCI Corporation,(Amex: CVM ) ... at the Rodman & Renshaw 9th Annual Healthcare Conference ... 5-7, 2007. The presentation,will be focused on its Phase ... product seeking to become a new first line standard ...
... the Potential ... INDIANAPOLIS and MUMBAI, India, Oct. 30 Eli,Lilly and Company ... into an,agreement with Glenmark Pharmaceuticals S.A. (GPSA) a wholly owned,subsidiary ... agreement, Lilly will acquire the rights to a portfolio of ...
Cached Medicine Technology:CEL-SCI to Present at Rodman & Renshaw 9th Annual Healthcare Conference 2Lilly and Glenmark Pharmaceuticals Announce License Agreement 2Lilly and Glenmark Pharmaceuticals Announce License Agreement 3Lilly and Glenmark Pharmaceuticals Announce License Agreement 4Lilly and Glenmark Pharmaceuticals Announce License Agreement 5
(Date:1/23/2015)... Hastings and Hastings, a law firm in Arizona that ... legal representation client review requests for slip and fall accidents ... in the number of slip and fall related accidents that ... With that said, a large number of injury victims are ... firm. Hastings and Hastings is a personal injury firm in ...
(Date:1/22/2015)... Liberty University has received accreditation for its ... the Council for Accreditation of Counseling & Related Educational ... Center for Counseling & Family Studies , is under the ... new School of Behavioral Sciences. Prior to the formation of ...
(Date:1/22/2015)... Woodloch Pines, an all-inclusive family resort ... as the number one best large hotel for families in ... for their annual Travelers’ Choice Awards. , TripAdvisor represents ... is home to millions of unbiased and honest traveler reviews. ...
(Date:1/22/2015)... is a seasoned and trusted leader who consistently delivers trendy ... have it lead the wedding dress industry into the future. ... for the global market. , “The CEO of VogueQueen is ... on continuing the goal of operational excellence and giving back ...
(Date:1/22/2015)... Blue Cross and Blue Shield of Minnesota (Blue Cross) wants ... “Live Fearless.” , The “Faces of Fearless” campaign ... how they or someone they know has faced a challenge, ... moment. By telling these types of stories through livefearlessmn.com, participants ...
Breaking Medicine News(10 mins):Health News:Hastings and Hastings Reports a Record Number of Client Review Requests for Slip and Fall Accidents in 2014 2Health News:Liberty University's Resident Master’s Counseling Program Receives CACREP Accreditation 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 2Health News:TripAdvisor Names Woodloch Pines Best Hotel for Families in America 3Health News:VogueQueen Unveils New Designs of Prom Dresses for 2015 2Health News:Blue Cross and Blue Shield of Minnesota to Showcase “Faces of Fearless” 2
... ... with no payout limits and is the first in the industry to do so. ... (Vocus) June 16, 2010 -- ... “No Dollar Limit” provision for their policy, an industry first. All pet insurance companies, ...
... ... stress by aiding in the creation of healthy serotonin levels , ... Springville, UT (PRWEB) June 16, 2010 -- Nutrifect introduces ... and restful sleep ; reduces cravings for junk food; and assists with healthy ...
... there so much disagreement about whether using recreational drugs ... shows that the debate about drugs might really be ... One theory -- the conventional wisdom in ... from people,s political ideology, level of religious commitment, and ...
... of the virus that causes chickenpox and shingles could lead ... Scientists at the University of Edinburgh devised a technique to ... them on to a biochip, before incubating the chip with ... They were able to pinpoint which proteins in the virus ...
... that even with genes that put them at higher ... improve heart function, according to research reported in ... Association journal. , Using data from the Emory Twins ... diet had greater heart rate variability (HRV) than those ...
... of a key player in a signaling pathway involved in ... cancer may offer hope for new targeted melanoma therapies. ... Center report that a signaling molecule, known as IKKβ, is ... the disease. The results, published June 7 in the ...
Cached Medicine News:Health News:Trupanion Announces an Industry First in Pet Insurance 2Health News:Trupanion Announces an Industry First in Pet Insurance 3Health News:Healthy Serotonin Levels Shown to Positively Affect many Important Functions of the Mind and Body. 2Health News:Sex, drugs and moral goals: Penn study of reproductive strategies and recreational drug use 2Health News:Sex, drugs and moral goals: Penn study of reproductive strategies and recreational drug use 3Health News:Twin study shows Mediterranean-style diet improves heart function 2Health News:Tumor target suggests personalized treatment for melanoma 2Health News:Tumor target suggests personalized treatment for melanoma 3
The collagen intracanicular plugs have a smooth proprietary finish that simplifies insertion of the plug. Collagen plugs are ideal for short term, diagnostic and post-surgical occlusion. Plugs are 2m...
Extended Duration absorbable plugs are designed to provide patient comfort for up to 3 months. This long lasting plug is effective and economical for transient dry eye symptoms following surgery. Ext...
The latest wave in punctum plugs! Unique design featureing reservoir indentations to reduce foreign body sensation. Elast™ - a proprietary formulated, hight performance Liquid Silicon Rubber ...
Attain Left-heart Lead Delivery Systems. Medtronic offers left-heart lead delivery systems to assist with accessing the coronary sinus (cs)....
Medicine Products: